MIRA Earnings — MIRA Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
MIRA — MIRA Pharmaceuticals, Inc. Common Stock
XNAS · Healthcare · Drug Manufacturers - General
Price$1.06
Market Cap$44.5M
P/E—
52W Range$0.90 – $2.45
Next Earnings2026-08-13
About MIRA Pharmaceuticals, Inc. Common Stock
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
